BRD4 Inhibitor-10 is primarily used in research and development for targeting BRD4, a protein involved in regulating gene expression. It is applied in studies focused on cancer therapy, as BRD4 plays a critical role in the growth and survival of certain cancer cells. By inhibiting BRD4, this compound helps in understanding its function and exploring potential treatments for cancers such as leukemia, lymphoma, and other malignancies. Additionally, it is utilized in epigenetic research to investigate the mechanisms of gene regulation and chromatin remodeling. Its application extends to drug discovery, where it serves as a tool for developing novel therapeutic agents targeting BRD4-related pathways.